1707 On Other Exchanges
1707 is not on other exchanges.

grape king bio ltd (1707) Snapshot

Previous Close
Day High
Day Low
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for GRAPE KING BIO LTD (1707)

Related News

No related news articles were found.

grape king bio ltd (1707) Related Businessweek News

No Related Businessweek News Found

grape king bio ltd (1707) Details

Grape King Bio Ltd primarily produces and sells pharmaceutical preparations, patent medicines, liquid tonics, drinks, and healthy foods in Taiwan. The company offers mushroom mycelium products, such as antrodia camphorata, ganoderma lucidum, cordyceps, coriolus versicolor, phellinus linteus, grifola frondosa, hericium erinaceum, lignosus rhinocerus, and armillaria mellea; and probiotics, including bifidobacterium, lactobacillus, and coccus. It also provides OEM/ODM services for lactic acid bacteria/yeast/mushroom mycelia fermentation, microbial fertilizers, biological pesticides, animal feed supplements, recombinant DNA bacteria, and other customized services by fermentation. The company was founded in 1969 and is headquartered in Taoyuan, Taiwan.

Founded in 1969

grape king bio ltd (1707) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

grape king bio ltd
Grape King Bio Ltd. Reports Consolidated Revenue Results for the Month and Year to Date of June 2018

Grape King Bio Ltd. reported consolidated revenue results for the month and year to date of June 2018. For the month, sales Revenues were TWD 812,857,000 compared to TWD 786,130,000 a year ago. For the year to date, sales Revenues were TWD 4,294,374,000 compared to TWD 3,951,578,000 a year ago.

Grape King Bio Ltd Announces Cash Dividend for the Year 2018, Payable on August 10, 2018

Grape King Bio Ltd. announced cash dividend of TWD 6.7 per share for the year 2018, total amount of cash distributed to shareholders TWD 903,199,074, payable on August 10, 2018, ex-dividend date is July 09, 2018 and record date is July 15, 2018.

Grape King Bio Ltd. Announces Consolidated Sales Results for the Month and Year to Date Ended May 2018

Grape King Bio Ltd. announced consolidated sales results for the month and year to date ended May 2018. For the month, the company reported net sales revenue of TWD 765,314,000 compared to TWD 746,504,000 a year ago. For the year to date, the company reported net sales revenue of TWD 3,481,517,000 compared to TWD 3,165,448,000 a year ago.


The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

1707 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 1707.
View Industry Companies

Industry Analysis


Industry Average

Valuation 1707 Industry Range
Price/Earnings 24.0x
Price/Sales 3.4x
Price/Book 5.8x
Price/Cash Flow 23.9x
TEV/Sales 3.0x

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact GRAPE KING BIO LTD, please visit www.grapeking.com.tw. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.